Clinical Trial: Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung Transplantation
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Pilot Study to Investigate the Clinical Effect of Orally Inhaled AP301 on Treatment of Primary Graft Dysfunction (PGD) in Mechanically Ventilated Patients After Primary Lu
Brief Summary: The purpose of this study is to investigate the effect of orally inhaled AP-301 on primary graft dysfunction after lung transplantation.
Detailed Summary:
Sponsor: Apeptico Forschung und Entwicklung GmbH
Current Primary Outcome: P/F ratio [ Time Frame: 7 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome: EVLW [ Time Frame: 7 days or until extubation ]
Original Secondary Outcome: Same as current
Information By: Apeptico Forschung und Entwicklung GmbH
Dates:
Date Received: March 21, 2014
Date Started: June 2013
Date Completion:
Last Updated: July 23, 2015
Last Verified: July 2015